Searched for
OCULAR TECHNOLOGIES
Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...- Novel contact lenses to diagnose glaucoma developedThe novel contact lenses contain micro-sensors that monitor changes in eye pressure, which is a sign of possible glaucoma. The data collect...
- Sun Pharma launches dry eye treatment product in CanadaThe product is the first dry eye treatment available in Canada that is delivered with nanomicellar (NCELL) technology, which improves the b...
- Stock market update: Pharma stocks jump up to 4%; Aurobindo Pharma, Sun Pharma hog limelightThe Nifty Pharma index was trading 2.43 per cent up at 10,644 around 10:45 am.
- NGOs, social sector companies bank on innovationDisruption has spread across several levels to address challenges of cost, hiring, scale of operations and the issue being addressed. Strat...
- Sun Pharma announces positive results in phase 3 study of eye care drugSeciera is a patented, novel drug developed by Ocular Technologies, a company recently acquired by Sun Pharma. This acquisition gave Sun Ph...
- Sun Pharma completes acquisition of Ocular Technologies SarlAll the necessary formalities for closure of the said transaction have been concluded and the company has successfully completed the acquis...
- Sun Pharma launches first branded drug BromSite in USThe launch marks Sun Pharma’s entry into the branded drugs business in the US, a segment that many generic drug companies are targeting as ...
- Brokerages see over 40% upside in Sun Pharma shares after 2-fold rise in consolidated Q2 net profitNet sales of the company increased by 13.20% YoY to Rs 7,764.03 crore for the quarter under review against Rs 6,585.16 crore in the same qu...
- Sun Pharma to buy Ocular Technologies from Auven TherapeuticsSun will pay Auven $40 million upfront, contingent development milestones and sales milestones, in addition to royalties on sales of Secier...
- USFDA nod for eyecare drug BromSite gives boost to Sun PharmaThe product will be commercialized through New Jersey-based Sun Ophthalmics, a division that Sun formed recently to route its specialty bra...
- Budget 2016: Medical device industry hopes for 'Make in India' sopsIndustry representatives are waiting for sops like increased fund allocation and tax holidays to push manufacturing in the sector.
- India must work towards meaningful climate deal at Paris: EcoSikhA pro-environment Sikh-American group said that India should commit itself to reducing carbon emissions and work towards a meaningful agree...
- USFDA denies approval for SPARC's anti-glaucoma eyedropSun Pharma Advanced Research Company (SPARC) today said the US health regulator has not approved its new drug application for anti-glaucoma...
- No USFDA approval for SPARC's anti-Glaucoma eyedropWhile the FDA did not seek any additional information for supporting clinical data, it sought additional information on certain labeling of...
- The promise of transparent electronics: Windscreens that double up as displaysA transparent conductor is a contradiction of sorts, as properties that allow transparency usually make a material an insulator.
- Biocon inks licensing pact with US-based Quark PharmaBiocon today said it has inked a pact with Quark Pharmaceuticals, Inc to develop a range of siRNA (small interfering RNA) based novel thera...
- Sun Pharma gains on JV to develop new drugsThe joint venture will leverage Sun Pharma’s global capabilities and experience in developing and manufacturing complex dosage forms and sp...
- Sun & Intrexon JV for ocular diseasesThe joint venture will leverage Sun Pharma's global capabilities and experience in developing and manufacturing complex dosage forms and sp...
- New facility for AurolaAravind Eye Hospital's Aurolab which produces Intra Ocular lens(IOL) and other surgical instruments, would have a new manufacturing facilit...
Load More
